Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7902361 Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy

Patent 7902361 was granted and assigned to Cyclacel on March, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Cyclacel

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

79023610

Patent Inventor Names

Daniella I. Zheleva0

Alex Perry0

Christopher Meades0

Kenneth Duncan0

Peter Martin Fischer0

Shudong Wang0

Darren Gibson0

David Blake0

...

Date of Patent

March 8, 2011

Patent Application Number

114084630

Date Filed

April 21, 2006

Patent Citations Received

‌

US Patent RE49850 N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds

‌

US Patent 11970491 N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amine derivatives as therapeutic compounds

Patent Primary Examiner

‌

Venkataraman Balasubramanian

Patent abstract

The present invention relates to compounds of formula I, or pharmaceutically acceptable salts thereof,

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7902361 Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API